VRC 01LSAlternative Names: VRC 01; VRC-HIVMAB080-00-AB; VRC01LS
Latest Information Update: 25 Jul 2016
At a glance
- Originator National Institute of Allergy and Infectious Diseases
- Developer National Institute of Allergy and Infectious Diseases; Xencor
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I HIV infections